calcium trisodium pentetate

Suppliers

Names

[ CAS No. ]:
12111-24-9

[ Name ]:
calcium trisodium pentetate

[Synonym ]:
Pentetate sodium calcium
CALCIUMDTPA
Pentetate Calcium Trisodium

Chemical & Physical Properties

[ Boiling Point ]:
721.1ºC at 760mmHg

[ Molecular Formula ]:
C14H18CaN3Na3O10

[ Molecular Weight ]:
497.35400

[ Flash Point ]:
389.9ºC

[ Exact Mass ]:
497.03100

[ PSA ]:
182.71000

[ Vapour Pressure ]:
9.53E-23mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MB8210000
CHEMICAL NAME :
Glycine, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)-, calcium trisodium salt
CAS REGISTRY NUMBER :
12111-24-9
LAST UPDATED :
199701
DATA ITEMS CITED :
13
MOLECULAR FORMULA :
C14-H18-N3-O10.Ca.3Na
MOLECULAR WEIGHT :
497.40
WISWESSER LINE NOTATION :
OV1N1VO&2N1VO2N1VO&1VO &-NA- 3 &-CA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2512 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7269 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
659 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1790 mg/kg
SEX/DURATION :
female 9-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
2685 mg/kg
SEX/DURATION :
female 9-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3581 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
30 gm/kg
SEX/DURATION :
female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3580 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
TYPE OF TEST :
DNA inhibition

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Rodent - rat Liver
DOSE/DURATION :
10 mmol/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 23,901,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X9954 No. of Facilities: 116 (estimated) No. of Industries: 1 No. of Occupations: 4 No. of Employees: 1702 (estimated) No. of Female Employees: 1258 (estimated)

Related Compounds

  • CALCIUM TRISODIUM DIETHYLENETRIAMINEPENTAACETATE HYDRATE
  • Diethylenetriaminepentaacetic Acid Calcium Trisodium Salt Hydrate
  • Calcium trinatrium diethylenetriaminepentaacetic acid hydrate
  • Calcium Petronate HMW
  • calcium,(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate
  • CALCIUM ACETYLACETONATE HYDRATE
  • [3-Cyclopropyl-5-(difluoromethyl)phenyl]methanol
  • 1-(Chloromethyl)-3-cyclopropyl-5-(difluoromethyl)benzene
  • tert-butyl N-{[3-(prop-2-yn-1-yl)phenyl]methyl}carbamate
  • Dimethyl[4-(piperidin-3-yloxy)but-2-yn-1-yl]amine
  • 1-[4-(Azetidin-3-yloxy)but-2-yn-1-yl]-4-methylpiperidine
  • 5-bromo-1-(cyclobutylmethyl)-1H-pyrazol-4-ol
  • 1-[3-Methyl-3-(2,2,2-trifluoroethyl)cyclobutyl]methanamine
  • Methyl({[3-methyl-3-(2,2,2-trifluoroethyl)cyclobutyl]methyl})amine
  • 4-[(azetidin-3-yl)methoxy]-1-(difluoromethyl)-1H-pyrazole
  • tert-butyl (2R)-3-hydroxy-3-(hydroxymethyl)-2-methyl-azetidine-1-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.